Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety of nontumor necrosis factor-targeted biologics in the COVID-19 pandemic.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety of nontumor necrosis factor-targeted biologics in the COVID-19 pandemic.
Safety of nontumor necrosis factor-targeted biologics in the COVID-19 pandemic. J Med Virol. 2021 02; 93(2):714-716.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Azetidines
Biological Products
Humans
Interleukins
Janus Kinase Inhibitors
Purines
Pyrazoles
Randomized Controlled Trials as Topic
Sulfonamides
Tumor Necrosis Factor-alpha